Stocks and Investing
Stocks and Investing
Tue, May 17, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jennifer Kim Maintained (AYTU) at Buy with Decreased Target to $100 on, May 17th, 2022
Jennifer Kim of Cantor Fitzgerald, Maintained "Aytu BioPharma, Inc." (AYTU) at Buy with Decreased Target from $220 to $100 on, May 17th, 2022.
Jennifer has made no other calls on AYTU in the last 4 months.
There is 1 other peer that has a rating on AYTU. Out of the 1 peers that are also analyzing AYTU, 0 agree with Jennifer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jennifer
- Vernon Bernardino of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $220 on, Thursday, April 28th, 2022
Contributing Sources